Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Chemogenetic Neuromodulation for Refractory Epilepsy

A major advance for neuromedicine: the first clinical report on a successful chemogenetic gene therapy for epilepsy. Chemogenetics modifies cells to express cell signaling receptors which respond to a desired small molecule drug rather than to the body’s own signals; adding a new “knob of control” to biology. I am optimistic that this modality will have immense impact across all areas of medicine.


In three patients with refractory epilepsy, hippocampal chemogenetic therapy plus low-dose clozapine was associated with a mean seizure-frequency reduction of 92.6%. Adverse events were grade 1 or 2.

AI-powered robots helping clean Europe’s ocean floor

AI-powered robots are currently helping scientists clean Europe’s ocean floor. Combining human-led efforts with artificial intelligence and robotics, the EU-funded SeaClear2.0 initiative is taking a collaborative approach to one of the ocean’s most persistent environmental problems.

Unlike many existing cleanup projects that focus on surface debris, this system targets waste that has already sunk to the seafloor. By addressing this deeper layer of pollution, the researchers aim to tackle a part of the problem that has long been overlooked.

The autonomous system features an aerial drone to detect waste, an underwater rover to find it on the seabed, and robotic grippers to bring it up to the surface.

Pill to treat pancreatic cancer hailed as ‘biggest breakthrough in decades’

A pill that can shrink and potentially eliminate pancreas tumours is being hailed as the biggest breakthrough treatment for the cancer in decades.

In one in 12 of the patients given the drug, daraxonrasib, during a trial, the cancer became undetectable, and the tumours stopped growing in almost all of the 61 patients. The trial participants had recently been diagnosed with advanced pancreatic cancer that had spread to other parts of the body.

Though doctors have said the pill cannot yet be considered a cure, and they do not know how long it can keep the disease at bay, they have said it is encouraging news because it appears it will offer patients more time, even if it does not cause full remission.

Heart-specific T cell responses: from antigens to disease mechanisms

In this Review, Gustavo Campos Ramos revisits the molecular composition of the heart from a T cell perspective and describes the most relevant cardiac antigens identified to date, providing a framework for the definition of cardiac antigens and heart specificity and a roadmap for tracking and analysing specific T cells across cardiac diseases to enable a deeper understanding of tissue-specific immune mechanisms in cardiovascular diseases.

New brain mapping tool reveals how neurons independently calculate motion

A ball flying toward your head, a car approaching as you cross the street, or — in caveman days — a predator suddenly appearing. To react quickly, your brain needs to instantly know not only that something is moving, but which way it’s going.

Scientists have long known that certain cells in the eye activate only when something moves in a particular direction, and they assumed the brain simply received that information directly from those eye cells. But no tool existed to confirm this hypothesis by mapping out the precise connections between cells in the eye and those in the brain.

Now, researchers at UC San Francisco have developed a new brain-mapping tool to trace these connections. They used the technology to show that the brain doesn’t just take the eye’s word for the direction of motion; some cells in the brain also compute it on their own.

Four-dimensional X-ray nano-holotomography reveals multiscale chemomechanics in composite graphite–silicon battery electrodes

4D nano-tomography identifies fast ionic transport pathways as key regulators of electrochemical activity and reversibility in graphite–silicon battery electrodes.